Squarepoint’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Squarepoint’s Portfolio MKUL Stock Details MKUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,751	Closed	-$206K	–	3590
2022 Q2	$206K	Buy	+15,751	New	+$92.9K	﹤0.01%	2464

Other funds holding MKUL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's MKUL Position: Q3 2022 in Review

Squarepoint sold out of Molekule Group, Inc. Common Stock (MKUL) in Q3 2022, closing a stake of 15,751 shares — an estimated $206K sold.

Squarepoint first reported a position in MKUL in Q2 2022 and held it in 1 quarter. The position peaked at $206K in Q2 2022. 17 funds tracked by Wall St. Rank hold MKUL as of Q3 2022.

Squarepoint reported no remaining Molekule Group, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Squarepoint sold 15,751 Molekule Group, Inc. Common Stock shares in Q3 2022, an estimated $206K.
Squarepoint first reported a position in Molekule Group, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Squarepoint's Molekule Group, Inc. Common Stock position peaked at $206K in Q2 2022.
17 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.